Clicky

ACADIA Pharmaceuticals Inc.(ACAD) News

Date Title
Jun 26 Acadia’s ‘very bullish’ sales forecast restores some confidence on Wall Street
Jun 25 Acadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value Drivers
Jun 24 Acadia Pharmaceuticals price target raised to $38 from $26 at RBC Capital
Jun 20 Acadia Pharmaceuticals (ACAD) Conducts Inducement Awards to Attract and Retain Top Talent
Jun 11 US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication
Jun 9 U.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of Acadia in NUPLAZID® (pimavanserin) Composition of Matter Patent
May 29 Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 27 Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise
Apr 13 Declining Stock and Solid Fundamentals: Is The Market Wrong About ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)?
Feb 13 Is the Options Market Predicting a Spike in ACADIA Pharmaceuticals (ACAD) Stock?
Feb 12 Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
Jan 14 Acadia Pharmaceuticals: Billion-Dollar Milestone and Global Expansion in 2025
Jan 14 Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Jan 14 Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome
Jan 2 Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing
Dec 30 Acadia Pharmaceuticals Set to Join S&P SmallCap 600
Oct 31 ACADIA Pharmaceuticals Inc (ACAD): Worst-Performing Growth Stock in 2024
Sep 3 High Growth Tech Stocks To Watch In September 2024
Aug 29 Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options
Jul 30 Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release